Avalon GloboCare Corp. (ALBT:NASDAQ) closed at $0.282 on July 21, 2026, unchanged on the day. The stock trades 90.3% below its 52-week high of $2.90 and 34.3% above its 52-week low of $0.210. Avalon GloboCare Corp. is part of the Health Care sector.
In 252 trading sessions since October 22, 2025, ALBT closed higher on 68 days (27%). Its best day was February 26, 2026 (+107.62%) and its worst was March 2, 2026 (-30.87%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 3 times.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology, and their clinical applications, and healthcare facility management. It has three reportable segments: real property operating segment which is the key revenue driver; medical-related consulting services segment; and development services and sales of developed products segment. The company focuses on the diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Find more stocks like ALBT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.